Pain relief in a neuropathy patient by lacosamide: Proof of principle of clinical translation from patient-specific iPS cell-derived nociceptors
Background: Small fiber neuropathy (SFN) is a severe and disabling chronic pain syndrome with no causal and limited symptomatic treatment options. Mechanistically based individual treatment is not available. We report an in-vitro predicted individualized treatment success in one therapy-refractory C...
Main Authors: | Barbara Namer, Diana Schmidt, Esther Eberhardt, Michele Maroni, Eva Dorfmeister, Inge Petter Kleggetveit, Luisa Kaluza, Jannis Meents, Aaron Gerlach, Zhixin Lin, Andreas Winterpacht, Elena Dragicevic, Zacharias Kohl, Jürgen Schüttler, Ingo Kurth, Torhild Warncke, Ellen Jorum, Beate Winner, Angelika Lampert |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396418305462 |
Similar Items
-
Pattern of Functional TTX-Resistant Sodium Channels Reveals a Developmental Stage of Human iPSC- and ESC-Derived Nociceptors
by: Esther Eberhardt, et al.
Published: (2015-09-01) -
SCN10A Mutation in a Patient with Erythromelalgia Enhances C-Fiber Activity Dependent Slowing.
by: Andreas M Kist, et al.
Published: (2016-01-01) -
Changes in Ionic Conductance Signature of Nociceptive Neurons Underlying Fabry Disease Phenotype
by: Barbara Namer, et al.
Published: (2017-07-01) -
Inhibition of visceral nociceptors
by: David E Reed, et al.
Published: (2014-04-01) -
Lacosamide in Pediatric Status Epilepticus
by: Juan A. Piantino
Published: (2017-02-01)